Clinical Trials
Braintumor Website

There are 8 trials:
Facility: University of Virginia
NCT Trial Name# of Centers

NCT01648348

  Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
242

NCT01381718

  Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
59

NCT02511405

  A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)
53

NCT02078648

  Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
16

NCT01380782

  BIBF 1120 for Recurrent High-Grade Gliomas
3

NCT02648633

  Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
1

NCT02624388

  Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
1

NCT03344250

  Phase I EGFR BATs in Newly Diagnosed Glioblastoma
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites